TRIM72 and neoplasm: The high expression of tripartite motif containing 72 (TRIM72) in patients with pCR is consistent with findings from lung cancer, where it was shown to inhibit cellular proliferation and tumor progression, and to enhance sensitivity to cisplatin [43].